Solid Biosciences (NASDAQ:SLDB) Price Target Raised to $16.00
Solid Biosciences (NASDAQ:SLDB – Free Report) had its price objective boosted by Chardan Capital from $15.00 to $16.00 in a report published on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. Other analysts have also issued reports about the stock. Wedbush initiated coverage on shares of Solid Biosciences in a […]
Solid Biosciences (NASDAQ:SLDB – Free Report) had its price objective boosted by Chardan Capital from $15.00 to $16.00 in a report published on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. Other analysts have also issued reports about the stock. Wedbush initiated coverage on shares of Solid Biosciences in a […]
